Cargando…
Respiratory Virus Vaccines
This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenz...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149605/ http://dx.doi.org/10.1016/B978-0-12-415847-4.00059-8 |
_version_ | 1783520841746612224 |
---|---|
author | Broadbent, Andrew J. Boonnak, Kobporn Subbarao, Kanta |
author_facet | Broadbent, Andrew J. Boonnak, Kobporn Subbarao, Kanta |
author_sort | Broadbent, Andrew J. |
collection | PubMed |
description | This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinical trials or in preclinical stages of development. The majority of studies evaluating respiratory virus vaccines measure serum antibody responses, because, although both cellular and humoral responses contribute to the clearance of a primary infection, neutralizing antibodies are known to protect against secondary infection. Humoral responses can be readily detected after vaccination with inactivated or subunit vaccines; however, fewer individuals seroconvert after vaccination with live vaccines. Alternative immune mechanisms such as mucosal antibody responses are probably responsible for protection by live attenuated vaccines, and immune correlates of protection are under investigation. |
format | Online Article Text |
id | pubmed-7149605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71496052020-04-13 Respiratory Virus Vaccines Broadbent, Andrew J. Boonnak, Kobporn Subbarao, Kanta Mucosal Immunology Article This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinical trials or in preclinical stages of development. The majority of studies evaluating respiratory virus vaccines measure serum antibody responses, because, although both cellular and humoral responses contribute to the clearance of a primary infection, neutralizing antibodies are known to protect against secondary infection. Humoral responses can be readily detected after vaccination with inactivated or subunit vaccines; however, fewer individuals seroconvert after vaccination with live vaccines. Alternative immune mechanisms such as mucosal antibody responses are probably responsible for protection by live attenuated vaccines, and immune correlates of protection are under investigation. 2015 2015-03-13 /pmc/articles/PMC7149605/ http://dx.doi.org/10.1016/B978-0-12-415847-4.00059-8 Text en Copyright © 2015 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Broadbent, Andrew J. Boonnak, Kobporn Subbarao, Kanta Respiratory Virus Vaccines |
title | Respiratory Virus Vaccines |
title_full | Respiratory Virus Vaccines |
title_fullStr | Respiratory Virus Vaccines |
title_full_unstemmed | Respiratory Virus Vaccines |
title_short | Respiratory Virus Vaccines |
title_sort | respiratory virus vaccines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149605/ http://dx.doi.org/10.1016/B978-0-12-415847-4.00059-8 |
work_keys_str_mv | AT broadbentandrewj respiratoryvirusvaccines AT boonnakkobporn respiratoryvirusvaccines AT subbaraokanta respiratoryvirusvaccines |